nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—ENPP1—renal system—muscle cancer	0.0184	0.0609	CbGeAlD
Ribavirin—ENPP1—tendon—muscle cancer	0.0143	0.0476	CbGeAlD
Ribavirin—NT5C2—smooth muscle tissue—muscle cancer	0.0139	0.0462	CbGeAlD
Ribavirin—NT5C2—renal system—muscle cancer	0.0134	0.0445	CbGeAlD
Ribavirin—ENPP1—head—muscle cancer	0.0123	0.0408	CbGeAlD
Ribavirin—SLC28A3—bone marrow—muscle cancer	0.0122	0.0404	CbGeAlD
Ribavirin—ENPP1—testis—muscle cancer	0.0119	0.0394	CbGeAlD
Ribavirin—IMPDH1—smooth muscle tissue—muscle cancer	0.0113	0.0375	CbGeAlD
Ribavirin—IMPDH1—renal system—muscle cancer	0.0109	0.0361	CbGeAlD
Ribavirin—NT5C2—tendon—muscle cancer	0.0105	0.0347	CbGeAlD
Ribavirin—NT5C2—bone marrow—muscle cancer	0.0101	0.0337	CbGeAlD
Ribavirin—NT5C2—vagina—muscle cancer	0.00971	0.0322	CbGeAlD
Ribavirin—NT5C2—head—muscle cancer	0.00897	0.0298	CbGeAlD
Ribavirin—ADK—smooth muscle tissue—muscle cancer	0.00891	0.0296	CbGeAlD
Ribavirin—NT5C2—testis—muscle cancer	0.00867	0.0288	CbGeAlD
Ribavirin—ADK—renal system—muscle cancer	0.00858	0.0285	CbGeAlD
Ribavirin—IMPDH1—tendon—muscle cancer	0.0085	0.0282	CbGeAlD
Ribavirin—IMPDH1—bone marrow—muscle cancer	0.00823	0.0273	CbGeAlD
Ribavirin—IMPDH1—vagina—muscle cancer	0.00788	0.0262	CbGeAlD
Ribavirin—ADK—cardiac atrium—muscle cancer	0.00768	0.0255	CbGeAlD
Ribavirin—SLC29A1—renal system—muscle cancer	0.00731	0.0243	CbGeAlD
Ribavirin—IMPDH1—head—muscle cancer	0.00728	0.0242	CbGeAlD
Ribavirin—IMPDH1—testis—muscle cancer	0.00704	0.0234	CbGeAlD
Ribavirin—ADK—tendon—muscle cancer	0.0067	0.0222	CbGeAlD
Ribavirin—SLC29A1—cardiac atrium—muscle cancer	0.00654	0.0217	CbGeAlD
Ribavirin—ADK—bone marrow—muscle cancer	0.00649	0.0215	CbGeAlD
Ribavirin—ADK—vagina—muscle cancer	0.00622	0.0206	CbGeAlD
Ribavirin—ADK—head—muscle cancer	0.00574	0.0191	CbGeAlD
Ribavirin—SLC29A1—tendon—muscle cancer	0.0057	0.0189	CbGeAlD
Ribavirin—ADK—testis—muscle cancer	0.00555	0.0184	CbGeAlD
Ribavirin—SLC29A1—bone marrow—muscle cancer	0.00552	0.0183	CbGeAlD
Ribavirin—SLC29A1—vagina—muscle cancer	0.00529	0.0176	CbGeAlD
Ribavirin—SLC29A1—head—muscle cancer	0.00489	0.0162	CbGeAlD
Ribavirin—SLC29A1—testis—muscle cancer	0.00472	0.0157	CbGeAlD
Ribavirin—Mood swings—Doxorubicin—muscle cancer	0.000728	0.00104	CcSEcCtD
Ribavirin—Ataxia—Doxorubicin—muscle cancer	0.000723	0.00103	CcSEcCtD
Ribavirin—Asthenia—Dactinomycin—muscle cancer	0.000722	0.00103	CcSEcCtD
Ribavirin—Neutropenia—Methotrexate—muscle cancer	0.000718	0.00103	CcSEcCtD
Ribavirin—Dehydration—Doxorubicin—muscle cancer	0.000715	0.00102	CcSEcCtD
Ribavirin—Thrombocytopenia—Etoposide—muscle cancer	0.000713	0.00102	CcSEcCtD
Ribavirin—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000713	0.00102	CcSEcCtD
Ribavirin—Tachycardia—Etoposide—muscle cancer	0.000711	0.00102	CcSEcCtD
Ribavirin—Abdominal pain—Vincristine—muscle cancer	0.000711	0.00102	CcSEcCtD
Ribavirin—Body temperature increased—Vincristine—muscle cancer	0.000711	0.00102	CcSEcCtD
Ribavirin—Skin disorder—Etoposide—muscle cancer	0.000708	0.00101	CcSEcCtD
Ribavirin—Erectile dysfunction—Methotrexate—muscle cancer	0.000707	0.00101	CcSEcCtD
Ribavirin—Dry skin—Doxorubicin—muscle cancer	0.000705	0.00101	CcSEcCtD
Ribavirin—Hyperhidrosis—Etoposide—muscle cancer	0.000704	0.00101	CcSEcCtD
Ribavirin—Abdominal pain upper—Doxorubicin—muscle cancer	0.000702	0.001	CcSEcCtD
Ribavirin—Photosensitivity reaction—Methotrexate—muscle cancer	0.0007	0.001	CcSEcCtD
Ribavirin—Breast disorder—Doxorubicin—muscle cancer	0.000695	0.000994	CcSEcCtD
Ribavirin—Anorexia—Etoposide—muscle cancer	0.000694	0.000994	CcSEcCtD
Ribavirin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000692	0.000991	CcSEcCtD
Ribavirin—Diarrhoea—Dactinomycin—muscle cancer	0.000689	0.000986	CcSEcCtD
Ribavirin—Pneumonia—Methotrexate—muscle cancer	0.000688	0.000985	CcSEcCtD
Ribavirin—Nasopharyngitis—Doxorubicin—muscle cancer	0.000687	0.000984	CcSEcCtD
Ribavirin—Infestation—Methotrexate—muscle cancer	0.000684	0.000979	CcSEcCtD
Ribavirin—Infestation NOS—Methotrexate—muscle cancer	0.000684	0.000979	CcSEcCtD
Ribavirin—Depression—Methotrexate—muscle cancer	0.000682	0.000976	CcSEcCtD
Ribavirin—Hypotension—Etoposide—muscle cancer	0.000681	0.000974	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000678	0.000971	CcSEcCtD
Ribavirin—Muscular weakness—Doxorubicin—muscle cancer	0.000678	0.00097	CcSEcCtD
Ribavirin—Renal failure—Methotrexate—muscle cancer	0.000673	0.000963	CcSEcCtD
Ribavirin—Abdominal distension—Doxorubicin—muscle cancer	0.000669	0.000957	CcSEcCtD
Ribavirin—Stomatitis—Methotrexate—muscle cancer	0.000667	0.000954	CcSEcCtD
Ribavirin—Conjunctivitis—Methotrexate—muscle cancer	0.000665	0.000952	CcSEcCtD
Ribavirin—Asthma—Doxorubicin—muscle cancer	0.000664	0.000951	CcSEcCtD
Ribavirin—Influenza—Doxorubicin—muscle cancer	0.000664	0.000951	CcSEcCtD
Ribavirin—Hypersensitivity—Vincristine—muscle cancer	0.000663	0.000948	CcSEcCtD
Ribavirin—Paraesthesia—Etoposide—muscle cancer	0.000654	0.000936	CcSEcCtD
Ribavirin—Pancreatitis—Doxorubicin—muscle cancer	0.000651	0.000932	CcSEcCtD
Ribavirin—Dyspnoea—Etoposide—muscle cancer	0.00065	0.00093	CcSEcCtD
Ribavirin—Somnolence—Etoposide—muscle cancer	0.000648	0.000927	CcSEcCtD
Ribavirin—Angina pectoris—Doxorubicin—muscle cancer	0.000647	0.000926	CcSEcCtD
Ribavirin—Hepatobiliary disease—Methotrexate—muscle cancer	0.000647	0.000926	CcSEcCtD
Ribavirin—Epistaxis—Methotrexate—muscle cancer	0.000645	0.000924	CcSEcCtD
Ribavirin—Asthenia—Vincristine—muscle cancer	0.000645	0.000923	CcSEcCtD
Ribavirin—Vomiting—Dactinomycin—muscle cancer	0.00064	0.000916	CcSEcCtD
Ribavirin—Bronchitis—Doxorubicin—muscle cancer	0.000639	0.000915	CcSEcCtD
Ribavirin—Rash—Dactinomycin—muscle cancer	0.000635	0.000908	CcSEcCtD
Ribavirin—Decreased appetite—Etoposide—muscle cancer	0.000633	0.000906	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Etoposide—muscle cancer	0.000629	0.0009	CcSEcCtD
Ribavirin—Fatigue—Etoposide—muscle cancer	0.000628	0.000899	CcSEcCtD
Ribavirin—Pain—Etoposide—muscle cancer	0.000623	0.000892	CcSEcCtD
Ribavirin—Constipation—Etoposide—muscle cancer	0.000623	0.000892	CcSEcCtD
Ribavirin—Neutropenia—Doxorubicin—muscle cancer	0.000621	0.000889	CcSEcCtD
Ribavirin—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000618	0.000884	CcSEcCtD
Ribavirin—Haemoglobin—Methotrexate—muscle cancer	0.000617	0.000884	CcSEcCtD
Ribavirin—Diarrhoea—Vincristine—muscle cancer	0.000615	0.000881	CcSEcCtD
Ribavirin—Haemorrhage—Methotrexate—muscle cancer	0.000614	0.000879	CcSEcCtD
Ribavirin—Hepatitis—Methotrexate—muscle cancer	0.000614	0.000879	CcSEcCtD
Ribavirin—Pollakiuria—Doxorubicin—muscle cancer	0.000614	0.000878	CcSEcCtD
Ribavirin—Pharyngitis—Methotrexate—muscle cancer	0.00061	0.000872	CcSEcCtD
Ribavirin—Urinary tract disorder—Methotrexate—muscle cancer	0.000607	0.000868	CcSEcCtD
Ribavirin—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000607	0.000868	CcSEcCtD
Ribavirin—Weight increased—Doxorubicin—muscle cancer	0.000605	0.000865	CcSEcCtD
Ribavirin—Urethral disorder—Methotrexate—muscle cancer	0.000602	0.000862	CcSEcCtD
Ribavirin—Weight decreased—Doxorubicin—muscle cancer	0.000601	0.00086	CcSEcCtD
Ribavirin—Feeling abnormal—Etoposide—muscle cancer	0.0006	0.000859	CcSEcCtD
Ribavirin—Hyperglycaemia—Doxorubicin—muscle cancer	0.000599	0.000858	CcSEcCtD
Ribavirin—Nausea—Dactinomycin—muscle cancer	0.000598	0.000856	CcSEcCtD
Ribavirin—Pneumonia—Doxorubicin—muscle cancer	0.000596	0.000853	CcSEcCtD
Ribavirin—Gastrointestinal pain—Etoposide—muscle cancer	0.000596	0.000853	CcSEcCtD
Ribavirin—Dizziness—Vincristine—muscle cancer	0.000595	0.000851	CcSEcCtD
Ribavirin—Infestation NOS—Doxorubicin—muscle cancer	0.000592	0.000848	CcSEcCtD
Ribavirin—Infestation—Doxorubicin—muscle cancer	0.000592	0.000848	CcSEcCtD
Ribavirin—Visual impairment—Methotrexate—muscle cancer	0.000592	0.000847	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000587	0.000841	CcSEcCtD
Ribavirin—Renal failure—Doxorubicin—muscle cancer	0.000582	0.000833	CcSEcCtD
Ribavirin—Erythema multiforme—Methotrexate—muscle cancer	0.000581	0.000831	CcSEcCtD
Ribavirin—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000581	0.000831	CcSEcCtD
Ribavirin—Urticaria—Etoposide—muscle cancer	0.000579	0.000828	CcSEcCtD
Ribavirin—Jaundice—Doxorubicin—muscle cancer	0.000577	0.000826	CcSEcCtD
Ribavirin—Stomatitis—Doxorubicin—muscle cancer	0.000577	0.000826	CcSEcCtD
Ribavirin—Abdominal pain—Etoposide—muscle cancer	0.000576	0.000824	CcSEcCtD
Ribavirin—Body temperature increased—Etoposide—muscle cancer	0.000576	0.000824	CcSEcCtD
Ribavirin—Conjunctivitis—Doxorubicin—muscle cancer	0.000576	0.000824	CcSEcCtD
Ribavirin—Urinary tract infection—Doxorubicin—muscle cancer	0.000576	0.000824	CcSEcCtD
Ribavirin—Eye disorder—Methotrexate—muscle cancer	0.000574	0.000821	CcSEcCtD
Ribavirin—Tinnitus—Methotrexate—muscle cancer	0.000573	0.00082	CcSEcCtD
Ribavirin—Vomiting—Vincristine—muscle cancer	0.000572	0.000818	CcSEcCtD
Ribavirin—Cardiac disorder—Methotrexate—muscle cancer	0.00057	0.000816	CcSEcCtD
Ribavirin—Rash—Vincristine—muscle cancer	0.000567	0.000812	CcSEcCtD
Ribavirin—Dermatitis—Vincristine—muscle cancer	0.000567	0.000811	CcSEcCtD
Ribavirin—Headache—Vincristine—muscle cancer	0.000563	0.000806	CcSEcCtD
Ribavirin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00056	0.000802	CcSEcCtD
Ribavirin—Epistaxis—Doxorubicin—muscle cancer	0.000559	0.0008	CcSEcCtD
Ribavirin—Angiopathy—Methotrexate—muscle cancer	0.000557	0.000798	CcSEcCtD
Ribavirin—Sinusitis—Doxorubicin—muscle cancer	0.000556	0.000795	CcSEcCtD
Ribavirin—Immune system disorder—Methotrexate—muscle cancer	0.000555	0.000794	CcSEcCtD
Ribavirin—Mediastinal disorder—Methotrexate—muscle cancer	0.000554	0.000792	CcSEcCtD
Ribavirin—Chills—Methotrexate—muscle cancer	0.000551	0.000789	CcSEcCtD
Ribavirin—Alopecia—Methotrexate—muscle cancer	0.000543	0.000777	CcSEcCtD
Ribavirin—Bradycardia—Doxorubicin—muscle cancer	0.000541	0.000775	CcSEcCtD
Ribavirin—Mental disorder—Methotrexate—muscle cancer	0.000538	0.00077	CcSEcCtD
Ribavirin—Hypersensitivity—Etoposide—muscle cancer	0.000537	0.000768	CcSEcCtD
Ribavirin—Malnutrition—Methotrexate—muscle cancer	0.000535	0.000765	CcSEcCtD
Ribavirin—Erythema—Methotrexate—muscle cancer	0.000535	0.000765	CcSEcCtD
Ribavirin—Haemoglobin—Doxorubicin—muscle cancer	0.000535	0.000765	CcSEcCtD
Ribavirin—Nausea—Vincristine—muscle cancer	0.000534	0.000765	CcSEcCtD
Ribavirin—Rhinitis—Doxorubicin—muscle cancer	0.000533	0.000763	CcSEcCtD
Ribavirin—Hepatitis—Doxorubicin—muscle cancer	0.000532	0.000761	CcSEcCtD
Ribavirin—Haemorrhage—Doxorubicin—muscle cancer	0.000532	0.000761	CcSEcCtD
Ribavirin—Hypoaesthesia—Doxorubicin—muscle cancer	0.000529	0.000757	CcSEcCtD
Ribavirin—Pharyngitis—Doxorubicin—muscle cancer	0.000528	0.000755	CcSEcCtD
Ribavirin—Urinary tract disorder—Doxorubicin—muscle cancer	0.000525	0.000752	CcSEcCtD
Ribavirin—Oedema peripheral—Doxorubicin—muscle cancer	0.000524	0.00075	CcSEcCtD
Ribavirin—Dysgeusia—Methotrexate—muscle cancer	0.000524	0.000749	CcSEcCtD
Ribavirin—Asthenia—Etoposide—muscle cancer	0.000523	0.000748	CcSEcCtD
Ribavirin—Connective tissue disorder—Doxorubicin—muscle cancer	0.000523	0.000748	CcSEcCtD
Ribavirin—Urethral disorder—Doxorubicin—muscle cancer	0.000521	0.000746	CcSEcCtD
Ribavirin—Back pain—Methotrexate—muscle cancer	0.000517	0.00074	CcSEcCtD
Ribavirin—Pruritus—Etoposide—muscle cancer	0.000515	0.000738	CcSEcCtD
Ribavirin—Visual impairment—Doxorubicin—muscle cancer	0.000513	0.000734	CcSEcCtD
Ribavirin—Vision blurred—Methotrexate—muscle cancer	0.000504	0.000721	CcSEcCtD
Ribavirin—Erythema multiforme—Doxorubicin—muscle cancer	0.000503	0.00072	CcSEcCtD
Ribavirin—Diarrhoea—Etoposide—muscle cancer	0.000498	0.000713	CcSEcCtD
Ribavirin—Eye disorder—Doxorubicin—muscle cancer	0.000497	0.000711	CcSEcCtD
Ribavirin—Ill-defined disorder—Methotrexate—muscle cancer	0.000496	0.00071	CcSEcCtD
Ribavirin—Tinnitus—Doxorubicin—muscle cancer	0.000496	0.00071	CcSEcCtD
Ribavirin—Anaemia—Methotrexate—muscle cancer	0.000494	0.000707	CcSEcCtD
Ribavirin—Cardiac disorder—Doxorubicin—muscle cancer	0.000494	0.000706	CcSEcCtD
Ribavirin—Flushing—Doxorubicin—muscle cancer	0.000494	0.000706	CcSEcCtD
Ribavirin—Angiopathy—Doxorubicin—muscle cancer	0.000483	0.000691	CcSEcCtD
Ribavirin—Malaise—Methotrexate—muscle cancer	0.000482	0.00069	CcSEcCtD
Ribavirin—Dizziness—Etoposide—muscle cancer	0.000482	0.000689	CcSEcCtD
Ribavirin—Immune system disorder—Doxorubicin—muscle cancer	0.00048	0.000688	CcSEcCtD
Ribavirin—Vertigo—Methotrexate—muscle cancer	0.00048	0.000688	CcSEcCtD
Ribavirin—Mediastinal disorder—Doxorubicin—muscle cancer	0.000479	0.000686	CcSEcCtD
Ribavirin—Leukopenia—Methotrexate—muscle cancer	0.000479	0.000685	CcSEcCtD
Ribavirin—Chills—Doxorubicin—muscle cancer	0.000477	0.000683	CcSEcCtD
Ribavirin—Arrhythmia—Doxorubicin—muscle cancer	0.000475	0.00068	CcSEcCtD
Ribavirin—Alopecia—Doxorubicin—muscle cancer	0.00047	0.000673	CcSEcCtD
Ribavirin—Cough—Methotrexate—muscle cancer	0.000467	0.000668	CcSEcCtD
Ribavirin—Mental disorder—Doxorubicin—muscle cancer	0.000466	0.000667	CcSEcCtD
Ribavirin—Convulsion—Methotrexate—muscle cancer	0.000463	0.000663	CcSEcCtD
Ribavirin—Vomiting—Etoposide—muscle cancer	0.000463	0.000663	CcSEcCtD
Ribavirin—Erythema—Doxorubicin—muscle cancer	0.000463	0.000663	CcSEcCtD
Ribavirin—Malnutrition—Doxorubicin—muscle cancer	0.000463	0.000663	CcSEcCtD
Ribavirin—Rash—Etoposide—muscle cancer	0.000459	0.000657	CcSEcCtD
Ribavirin—Dermatitis—Etoposide—muscle cancer	0.000459	0.000657	CcSEcCtD
Ribavirin—Headache—Etoposide—muscle cancer	0.000456	0.000653	CcSEcCtD
Ribavirin—Flatulence—Doxorubicin—muscle cancer	0.000456	0.000653	CcSEcCtD
Ribavirin—Chest pain—Methotrexate—muscle cancer	0.000455	0.000651	CcSEcCtD
Ribavirin—Myalgia—Methotrexate—muscle cancer	0.000455	0.000651	CcSEcCtD
Ribavirin—Arthralgia—Methotrexate—muscle cancer	0.000455	0.000651	CcSEcCtD
Ribavirin—Tension—Doxorubicin—muscle cancer	0.000454	0.00065	CcSEcCtD
Ribavirin—Dysgeusia—Doxorubicin—muscle cancer	0.000453	0.000649	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000452	0.000647	CcSEcCtD
Ribavirin—Discomfort—Methotrexate—muscle cancer	0.00045	0.000644	CcSEcCtD
Ribavirin—Nervousness—Doxorubicin—muscle cancer	0.00045	0.000644	CcSEcCtD
Ribavirin—Back pain—Doxorubicin—muscle cancer	0.000448	0.000641	CcSEcCtD
Ribavirin—Muscle spasms—Doxorubicin—muscle cancer	0.000445	0.000637	CcSEcCtD
Ribavirin—Confusional state—Methotrexate—muscle cancer	0.00044	0.00063	CcSEcCtD
Ribavirin—Anaphylactic shock—Methotrexate—muscle cancer	0.000436	0.000625	CcSEcCtD
Ribavirin—Vision blurred—Doxorubicin—muscle cancer	0.000436	0.000624	CcSEcCtD
Ribavirin—Nausea—Etoposide—muscle cancer	0.000433	0.000619	CcSEcCtD
Ribavirin—Ill-defined disorder—Doxorubicin—muscle cancer	0.00043	0.000615	CcSEcCtD
Ribavirin—Nervous system disorder—Methotrexate—muscle cancer	0.000428	0.000612	CcSEcCtD
Ribavirin—Anaemia—Doxorubicin—muscle cancer	0.000428	0.000612	CcSEcCtD
Ribavirin—Thrombocytopenia—Methotrexate—muscle cancer	0.000427	0.000611	CcSEcCtD
Ribavirin—Agitation—Doxorubicin—muscle cancer	0.000425	0.000609	CcSEcCtD
Ribavirin—Skin disorder—Methotrexate—muscle cancer	0.000424	0.000607	CcSEcCtD
Ribavirin—Hyperhidrosis—Methotrexate—muscle cancer	0.000422	0.000604	CcSEcCtD
Ribavirin—Malaise—Doxorubicin—muscle cancer	0.000418	0.000598	CcSEcCtD
Ribavirin—Vertigo—Doxorubicin—muscle cancer	0.000416	0.000595	CcSEcCtD
Ribavirin—Anorexia—Methotrexate—muscle cancer	0.000416	0.000595	CcSEcCtD
Ribavirin—Syncope—Doxorubicin—muscle cancer	0.000415	0.000594	CcSEcCtD
Ribavirin—Leukopenia—Doxorubicin—muscle cancer	0.000414	0.000593	CcSEcCtD
Ribavirin—Palpitations—Doxorubicin—muscle cancer	0.000409	0.000586	CcSEcCtD
Ribavirin—Hypotension—Methotrexate—muscle cancer	0.000408	0.000584	CcSEcCtD
Ribavirin—Loss of consciousness—Doxorubicin—muscle cancer	0.000407	0.000582	CcSEcCtD
Ribavirin—Cough—Doxorubicin—muscle cancer	0.000404	0.000578	CcSEcCtD
Ribavirin—Convulsion—Doxorubicin—muscle cancer	0.000401	0.000574	CcSEcCtD
Ribavirin—Hypertension—Doxorubicin—muscle cancer	0.0004	0.000572	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000398	0.000569	CcSEcCtD
Ribavirin—Insomnia—Methotrexate—muscle cancer	0.000395	0.000565	CcSEcCtD
Ribavirin—Chest pain—Doxorubicin—muscle cancer	0.000394	0.000564	CcSEcCtD
Ribavirin—Myalgia—Doxorubicin—muscle cancer	0.000394	0.000564	CcSEcCtD
Ribavirin—Arthralgia—Doxorubicin—muscle cancer	0.000394	0.000564	CcSEcCtD
Ribavirin—Anxiety—Doxorubicin—muscle cancer	0.000393	0.000562	CcSEcCtD
Ribavirin—Paraesthesia—Methotrexate—muscle cancer	0.000392	0.000561	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000391	0.00056	CcSEcCtD
Ribavirin—Discomfort—Doxorubicin—muscle cancer	0.000389	0.000557	CcSEcCtD
Ribavirin—Dyspnoea—Methotrexate—muscle cancer	0.000389	0.000557	CcSEcCtD
Ribavirin—Somnolence—Methotrexate—muscle cancer	0.000388	0.000555	CcSEcCtD
Ribavirin—Dry mouth—Doxorubicin—muscle cancer	0.000385	0.000552	CcSEcCtD
Ribavirin—Dyspepsia—Methotrexate—muscle cancer	0.000384	0.00055	CcSEcCtD
Ribavirin—Confusional state—Doxorubicin—muscle cancer	0.000381	0.000545	CcSEcCtD
Ribavirin—Decreased appetite—Methotrexate—muscle cancer	0.000379	0.000543	CcSEcCtD
Ribavirin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000378	0.000541	CcSEcCtD
Ribavirin—Oedema—Doxorubicin—muscle cancer	0.000378	0.000541	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000377	0.000539	CcSEcCtD
Ribavirin—Fatigue—Methotrexate—muscle cancer	0.000376	0.000538	CcSEcCtD
Ribavirin—Pain—Methotrexate—muscle cancer	0.000373	0.000534	CcSEcCtD
Ribavirin—Shock—Doxorubicin—muscle cancer	0.000372	0.000532	CcSEcCtD
Ribavirin—Nervous system disorder—Doxorubicin—muscle cancer	0.000371	0.00053	CcSEcCtD
Ribavirin—Thrombocytopenia—Doxorubicin—muscle cancer	0.00037	0.000529	CcSEcCtD
Ribavirin—Tachycardia—Doxorubicin—muscle cancer	0.000369	0.000528	CcSEcCtD
Ribavirin—Skin disorder—Doxorubicin—muscle cancer	0.000367	0.000525	CcSEcCtD
Ribavirin—Hyperhidrosis—Doxorubicin—muscle cancer	0.000365	0.000523	CcSEcCtD
Ribavirin—Anorexia—Doxorubicin—muscle cancer	0.00036	0.000515	CcSEcCtD
Ribavirin—Feeling abnormal—Methotrexate—muscle cancer	0.00036	0.000515	CcSEcCtD
Ribavirin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000357	0.000511	CcSEcCtD
Ribavirin—Hypotension—Doxorubicin—muscle cancer	0.000353	0.000505	CcSEcCtD
Ribavirin—Urticaria—Methotrexate—muscle cancer	0.000347	0.000496	CcSEcCtD
Ribavirin—Abdominal pain—Methotrexate—muscle cancer	0.000345	0.000494	CcSEcCtD
Ribavirin—Body temperature increased—Methotrexate—muscle cancer	0.000345	0.000494	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000344	0.000493	CcSEcCtD
Ribavirin—Insomnia—Doxorubicin—muscle cancer	0.000342	0.000489	CcSEcCtD
Ribavirin—Paraesthesia—Doxorubicin—muscle cancer	0.000339	0.000486	CcSEcCtD
Ribavirin—Dyspnoea—Doxorubicin—muscle cancer	0.000337	0.000482	CcSEcCtD
Ribavirin—Somnolence—Doxorubicin—muscle cancer	0.000336	0.000481	CcSEcCtD
Ribavirin—Dyspepsia—Doxorubicin—muscle cancer	0.000333	0.000476	CcSEcCtD
Ribavirin—Decreased appetite—Doxorubicin—muscle cancer	0.000328	0.00047	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000326	0.000467	CcSEcCtD
Ribavirin—Fatigue—Doxorubicin—muscle cancer	0.000326	0.000466	CcSEcCtD
Ribavirin—Pain—Doxorubicin—muscle cancer	0.000323	0.000462	CcSEcCtD
Ribavirin—Constipation—Doxorubicin—muscle cancer	0.000323	0.000462	CcSEcCtD
Ribavirin—Hypersensitivity—Methotrexate—muscle cancer	0.000322	0.00046	CcSEcCtD
Ribavirin—Asthenia—Methotrexate—muscle cancer	0.000313	0.000448	CcSEcCtD
Ribavirin—Feeling abnormal—Doxorubicin—muscle cancer	0.000311	0.000446	CcSEcCtD
Ribavirin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000309	0.000442	CcSEcCtD
Ribavirin—Pruritus—Methotrexate—muscle cancer	0.000309	0.000442	CcSEcCtD
Ribavirin—Urticaria—Doxorubicin—muscle cancer	0.0003	0.00043	CcSEcCtD
Ribavirin—Abdominal pain—Doxorubicin—muscle cancer	0.000299	0.000427	CcSEcCtD
Ribavirin—Body temperature increased—Doxorubicin—muscle cancer	0.000299	0.000427	CcSEcCtD
Ribavirin—Diarrhoea—Methotrexate—muscle cancer	0.000299	0.000427	CcSEcCtD
Ribavirin—Dizziness—Methotrexate—muscle cancer	0.000289	0.000413	CcSEcCtD
Ribavirin—Hypersensitivity—Doxorubicin—muscle cancer	0.000278	0.000398	CcSEcCtD
Ribavirin—Vomiting—Methotrexate—muscle cancer	0.000277	0.000397	CcSEcCtD
Ribavirin—Rash—Methotrexate—muscle cancer	0.000275	0.000394	CcSEcCtD
Ribavirin—Dermatitis—Methotrexate—muscle cancer	0.000275	0.000393	CcSEcCtD
Ribavirin—Headache—Methotrexate—muscle cancer	0.000273	0.000391	CcSEcCtD
Ribavirin—Asthenia—Doxorubicin—muscle cancer	0.000271	0.000388	CcSEcCtD
Ribavirin—Pruritus—Doxorubicin—muscle cancer	0.000267	0.000383	CcSEcCtD
Ribavirin—Nausea—Methotrexate—muscle cancer	0.000259	0.000371	CcSEcCtD
Ribavirin—Diarrhoea—Doxorubicin—muscle cancer	0.000259	0.00037	CcSEcCtD
Ribavirin—Dizziness—Doxorubicin—muscle cancer	0.00025	0.000358	CcSEcCtD
Ribavirin—Vomiting—Doxorubicin—muscle cancer	0.00024	0.000344	CcSEcCtD
Ribavirin—Rash—Doxorubicin—muscle cancer	0.000238	0.000341	CcSEcCtD
Ribavirin—Dermatitis—Doxorubicin—muscle cancer	0.000238	0.000341	CcSEcCtD
Ribavirin—Headache—Doxorubicin—muscle cancer	0.000237	0.000339	CcSEcCtD
Ribavirin—Nausea—Doxorubicin—muscle cancer	0.000224	0.000321	CcSEcCtD
